Clinical Trial Update: Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets [Phase 3]

View source ↗

Summary

Phase 3 trial investigating paricalcitol to lower parathyroid hormone in familial hypophosphatemic rickets completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism
• Hypophosphatemia Familial

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Yale University | Conditions: Hypophosphatemia, Familial, Hyperparathyroidism | Phase 3 | Status: COMPLETED | Results posted: 2014-10-28